|
|
|
|
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
|
Laporte Road, Stallingborough
|
|
|
|
Grimsby, North East Lincolnshire, DN40 2PR, UK
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Title of each class
|
Trading Symbol(s)
|
Name of exchange on which registered
|
|
|
|
|
| Item 2.02. |
Results of Operations and Financial Condition.
|
| Item 9.01. |
Financial Statements and Exhibits.
|
|
Exhibit
No.
|
Description
|
|
|
Earnings Release, dated August 5, 2026.
|
||
|
104
|
Inline XBRL for the cover page of this Current Report on Form 8-K.
|
|
TRONOX HOLDINGS PLC
|
|||
|
Date: August 6, 2026
|
By:
|
|
/s/ Jeffrey N. Neuman
|
|
Name: Jeffrey N. Neuman
|
|||
|
Title: Senior Vice President, General Counsel and Secretary
|

| • |
Revenue of $868 million, a 14% increase compared to the prior quarter and a 19% increase compared to the prior year
|
| • |
Loss from operations of $21 million; net loss attributable to Tronox of $171 million (including $103 million tax valuation allowance); adjusted net loss attributable to Tronox was $82 million (non-GAAP)
|
| • |
GAAP diluted loss per share was $1.07; Adjusted diluted loss per share was $0.51 (non-GAAP)
|
| • |
Adjusted EBITDA of $73 million; Adjusted EBITDA margin of 8.4% (non-GAAP)
|
| • |
Capital expenditures of $45 million
|
| • |
Generated free cash flow of $60 million
|
| • |
Expect to deliver meaningful positive free cash flow for full year 2026, with Q3 relatively neutral
|
| • |
Expect Q3 2026 TiO2 volumes to be down moderately, in the mid-single-digit percentage range, in-line with normal, seasonal patterns
|
| • |
Expect Q3 zircon volumes to moderate slightly compared to Q2, due to inventory availability following a very strong first half
|
| • |
TiO2 pricing expected to improve sequentially in the mid-single-digit percentage range and zircon pricing to improve in the mid- to high single-digit percentage range in
Q3 2026
|
| • |
Q3 2026 Adjusted EBITDA expected to be $95-$115 million
|
|
($M unless otherwise noted)
|
Q2 2026
|
Q2 2025
|
Y-o-Y%∆
|
|
Q1 2026
|
Q-o-Q%∆
|
|
|||||||||||
|
Revenue
|
$
|
868
|
$
|
731
|
19
|
%
|
$
|
760
|
14
|
%
|
||||||||
|
TiO2
|
$
|
700
|
$
|
587
|
19
|
%
|
$
|
616
|
14
|
%
|
||||||||
|
Zircon
|
$
|
97
|
$
|
68
|
43
|
%
|
$
|
89
|
9
|
%
|
||||||||
|
Other products
|
$
|
71
|
$
|
76
|
(7
|
)%
|
$
|
55
|
29
|
%
|
||||||||
|
(Loss) from operations
|
$
|
(21
|
)
|
$
|
(35
|
)
|
n/
|
m
|
$
|
(41
|
)
|
n/
|
m
|
|||||
|
Net (loss) attributable to Tronox
|
$
|
(171
|
)
|
$
|
(84
|
)
|
n/
|
m
|
$
|
(103
|
)
|
n/
|
m
|
|||||
|
GAAP diluted (loss) per share
|
$
|
(1.07
|
)
|
$
|
(0.53
|
)
|
n/
|
m
|
$
|
(0.65
|
)
|
n/
|
m
|
|||||
|
Adjusted diluted (loss) per share
|
$
|
(0.51
|
)
|
$
|
(0.28
|
)
|
n/
|
m
|
$
|
(0.55
|
)
|
n/
|
m
|
|||||
|
Adjusted EBITDA
|
$
|
73
|
$
|
93
|
(22
|
)%
|
$
|
62
|
18
|
%
|
||||||||
|
Adjusted EBITDA Margin %
|
8.4
|
%
|
12.7
|
%
|
(430) bps
|
8.2
|
%
|
20 bps
|
||||||||||
|
Free cash flow
|
$
|
60
|
$
|
(55
|
)
|
n/
|
m
|
$
|
(135
|
)
|
n/
|
m
|
|
|
||||||
|
Y-o-Y % ∆
|
Q-o-Q % ∆
|
|||||
|
Volume
|
Price / Mix
|
FX
|
Volume
|
Price / Mix
|
FX
|
|
|
TiO2
|
18 %
|
0%
|
1%
|
9 %
|
5 %
|
0 %
|
|
Zircon
|
61 %
|
(18)%
|
—
|
4 %
|
5 %
|
—
|
|
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
||||||||||||||
|
|
2026
|
2025
|
2026
|
2025
|
||||||||||||
|
Net sales
|
$
|
868
|
$
|
731
|
$
|
1,628
|
$
|
1,469
|
||||||||
|
Cost of goods sold
|
813
|
652
|
1,529
|
1,291
|
||||||||||||
|
Gross profit
|
55
|
79
|
99
|
178
|
||||||||||||
|
Restructuring and other charges
|
4
|
42
|
18
|
128
|
||||||||||||
|
Selling, general and administrative expenses
|
72
|
72
|
143
|
146
|
||||||||||||
|
Loss from operations
|
(21
|
)
|
(35
|
)
|
(62
|
)
|
(96
|
)
|
||||||||
|
Interest expense
|
(56
|
)
|
(45
|
)
|
(109
|
)
|
(87
|
)
|
||||||||
|
Interest income
|
—
|
1
|
2
|
3
|
||||||||||||
|
Other income (expense), net
|
10
|
(2
|
)
|
(2
|
)
|
(7
|
)
|
|||||||||
|
Loss before income taxes
|
(67
|
)
|
(81
|
)
|
(171
|
)
|
(187
|
)
|
||||||||
|
Income tax provision
|
(106
|
)
|
(4
|
)
|
(106
|
)
|
(9
|
)
|
||||||||
|
Net loss
|
(173
|
)
|
(85
|
)
|
(277
|
)
|
(196
|
)
|
||||||||
|
Net loss attributable to noncontrolling interest
|
(2
|
)
|
(1
|
)
|
(3
|
)
|
(1
|
)
|
||||||||
|
Net loss attributable to Tronox Holdings plc
|
$
|
(171
|
)
|
$
|
(84
|
)
|
$
|
(274
|
)
|
$
|
(195
|
)
|
||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Loss per share:
|
||||||||||||||||
|
Basic
|
$
|
(1.07
|
)
|
$
|
(0.53
|
)
|
$
|
(1.72
|
)
|
$
|
(1.23
|
)
|
||||
|
Diluted
|
$
|
(1.07
|
)
|
$
|
(0.53
|
)
|
$
|
(1.72
|
)
|
$
|
(1.23
|
)
|
||||
|
|
||||||||||||||||
|
Weighted average shares outstanding, basic (in thousands)
|
159,841
|
158,561
|
159,444
|
158,358
|
||||||||||||
|
Weighted average shares outstanding, diluted (in thousands)
|
159,841
|
158,561
|
159,444
|
158,358
|
||||||||||||
|
|
||||||||||||||||
|
Other Operating Data:
|
||||||||||||||||
|
Capital expenditures
|
45
|
83
|
112
|
193
|
||||||||||||
|
Depreciation, depletion and amortization expense
|
76
|
74
|
151
|
145
|
||||||||||||
|
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
||||||||||||||
|
|
2026
|
2025
|
2026
|
2025
|
||||||||||||
|
|
||||||||||||||||
|
Net loss attributable to Tronox Holdings plc (U.S. GAAP)
|
$
|
(171
|
)
|
$
|
(84
|
)
|
$
|
(274
|
)
|
$
|
(195
|
)
|
||||
|
Gain on sale of Fuzhou (a)
|
(20
|
)
|
—
|
(20
|
)
|
—
|
||||||||||
|
Restructuring and other charges (b)
|
4
|
38
|
18
|
124
|
||||||||||||
|
Tax valuation allowance (c)
|
103
|
—
|
103
|
—
|
||||||||||||
|
Other (d)
|
2
|
1
|
3
|
2
|
||||||||||||
|
Adjusted net loss attributable to Tronox Holdings plc (non-U.S. GAAP)
|
$
|
(82
|
)
|
$
|
(45
|
)
|
$
|
(170
|
)
|
$
|
(69
|
)
|
||||
|
Diluted net loss per share (U.S. GAAP)
|
$
|
(1.07
|
)
|
$
|
(0.53
|
)
|
$
|
(1.72
|
)
|
$
|
(1.23
|
)
|
||||
|
Gain on sale of Fuzhou, per share
|
(0.13
|
)
|
—
|
(0.13
|
)
|
—
|
||||||||||
|
Restructuring and other charges, per share
|
0.03
|
0.24
|
0.12
|
0.78
|
||||||||||||
|
Tax valuation allowance, per share
|
0.65
|
—
|
0.65
|
—
|
||||||||||||
|
Other, per share
|
0.01
|
0.01
|
0.01
|
0.01
|
||||||||||||
|
Diluted adjusted net loss per share attributable to Tronox Holdings plc (non-U.S. GAAP) (1)
|
$
|
(0.51
|
)
|
$
|
(0.28
|
)
|
$
|
(1.07
|
)
|
$
|
(0.44
|
)
|
||||
|
Weighted average shares outstanding, diluted (in thousands)
|
159,841
|
158,561
|
159,444
|
158,358
|
||||||||||||
|
|
June 30, 2026
|
December 31, 2025
|
||||||
|
ASSETS
|
||||||||
|
Current Assets
|
||||||||
|
Cash and cash equivalents
|
$
|
194
|
$
|
199
|
||||
|
Restricted cash
|
12
|
12
|
||||||
|
Accounts receivable (net of allowance for credit losses of $1 and $1 as of June 30, 2026 and December 31, 2025,
respectively)
|
363
|
289
|
||||||
|
Inventories, net
|
1,458
|
1,652
|
||||||
|
Prepaid and other assets
|
113
|
112
|
||||||
|
Income taxes receivable
|
1
|
1
|
||||||
|
Total current assets
|
2,141
|
2,265
|
||||||
|
Noncurrent Assets
|
||||||||
|
Property, plant and equipment, net
|
1,988
|
2,007
|
||||||
|
Mineral leaseholds, net
|
595
|
608
|
||||||
|
Intangible assets, net
|
203
|
214
|
||||||
|
Lease right of use assets, net
|
180
|
173
|
||||||
|
Deferred tax assets
|
727
|
833
|
||||||
|
Other long-term assets
|
116
|
117
|
||||||
|
Total assets
|
$
|
5,950
|
$
|
6,217
|
||||
|
LIABILITIES AND EQUITY
|
||||||||
|
Current Liabilities
|
||||||||
|
Accounts payable
|
$
|
404
|
$
|
481
|
||||
|
Accrued liabilities
|
254
|
274
|
||||||
|
Short-term lease liabilities
|
24
|
22
|
||||||
|
Obligations under inventory financing arrangement
|
50
|
50
|
||||||
|
Short-term debt
|
68
|
51
|
||||||
|
Long-term debt due within one year
|
39
|
39
|
||||||
|
Income taxes payable
|
1
|
2
|
||||||
|
Total current liabilities
|
840
|
919
|
||||||
|
Noncurrent Liabilities
|
||||||||
|
Long-term debt, net
|
3,123
|
3,132
|
||||||
|
Pension and postretirement healthcare benefits
|
80
|
81
|
||||||
|
Asset retirement obligations
|
209
|
198
|
||||||
|
Environmental liabilities
|
30
|
39
|
||||||
|
Long-term lease liabilities
|
156
|
148
|
||||||
|
Deferred tax liabilities
|
212
|
208
|
||||||
|
Other long-term liabilities
|
109
|
43
|
||||||
|
Total liabilities
|
4,759
|
4,768
|
||||||
|
Commitments and Contingencies
|
||||||||
|
Shareholders’ Equity
|
||||||||
|
Tronox Holdings plc ordinary shares, par value $0.01 — 159,700,029 shares issued and outstanding at June 30, 2026 and
158,557,858 shares issued and outstanding at December 31, 2025
|
2
|
2
|
||||||
|
Capital in excess of par value
|
2,097
|
2,103
|
||||||
|
(Accumulated deficit) retained earnings
|
(244
|
)
|
30
|
|||||
|
Accumulated other comprehensive loss
|
(694
|
)
|
(717
|
)
|
||||
|
Total Tronox Holdings plc shareholders’ equity
|
1,161
|
1,418
|
||||||
|
Noncontrolling interest
|
30
|
31
|
||||||
|
Total equity
|
1,191
|
1,449
|
||||||
|
Total liabilities and equity
|
$
|
5,950
|
$
|
6,217
|
||||
|
|
Six Months Ended June 30,
|
|||||||
|
|
2026
|
2025
|
||||||
|
Cash Flows from Operating Activities:
|
||||||||
|
Net loss
|
$
|
(277
|
)
|
$
|
(196
|
)
|
||
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
|
||||||||
|
Depreciation, depletion and amortization
|
151
|
145
|
||||||
|
Deferred income taxes
|
106
|
7
|
||||||
|
Share-based compensation expense
|
11
|
9
|
||||||
|
Amortization of deferred debt issuance costs and discount on debt
|
6
|
5
|
||||||
|
Restructuring and other charges
|
18
|
128
|
||||||
|
Other non-cash items affecting net loss
|
9
|
29
|
||||||
|
Changes in assets and liabilities:
|
||||||||
|
Increase in accounts receivable, net of allowance for credit losses
|
(74
|
)
|
(19
|
)
|
||||
|
Decrease (increase) in inventories, net
|
191
|
(76
|
)
|
|||||
|
Decrease in prepaid and other assets
|
21
|
29
|
||||||
|
Restructuring payments
|
(29
|
)
|
(27
|
)
|
||||
|
Decrease in accounts payable and accrued liabilities
|
(84
|
)
|
(23
|
)
|
||||
|
Net changes in income tax payables and receivables
|
-
|
(5
|
)
|
|||||
|
Changes in other non-current assets and liabilities
|
(12
|
)
|
(10
|
)
|
||||
|
Cash provided by (used in) operating activities
|
37
|
(4
|
)
|
|||||
|
Cash Flows from Investing Activities:
|
||||||||
|
Capital expenditures
|
(112
|
)
|
(193
|
)
|
||||
|
Loans
|
-
|
15
|
||||||
|
Proceeds from dispositions and asset sales
|
15
|
2
|
||||||
|
Cash used in investing activities
|
(97
|
)
|
(176
|
)
|
||||
|
Cash Flows from Financing Activities:
|
||||||||
|
Repayments of short-term debt
|
(99
|
)
|
(11
|
)
|
||||
|
Repayments of long-term debt
|
(16
|
)
|
(14
|
)
|
||||
|
Repayments of inventory financing arrangement
|
(50
|
)
|
-
|
|||||
|
Proceeds from inventory financing arrangement
|
50
|
-
|
||||||
|
Proceeds from sale and leaseback transaction
|
75
|
-
|
||||||
|
Proceeds from short-term debt
|
116
|
203
|
||||||
|
Debt issuance costs
|
(2
|
)
|
(1
|
)
|
||||
|
Sale and leaseback transaction costs
|
(1
|
)
|
-
|
|||||
|
Dividends paid
|
(16
|
)
|
(20
|
)
|
||||
|
Restricted stock and performance-based shares settled in cash for withholding taxes
|
-
|
(1
|
)
|
|||||
|
Cash provided by financing activities
|
57
|
156
|
||||||
|
Effects of exchange rate changes on cash and cash equivalents and restricted cash
|
(2
|
)
|
5
|
|||||
|
Net decrease in cash and cash equivalents and restricted cash
|
(5
|
)
|
(19
|
)
|
||||
|
Cash and cash equivalents and restricted cash at beginning of period
|
211
|
152
|
||||||
|
Cash and cash equivalents and restricted cash at end of period
|
$
|
206
|
$
|
133
|
||||
|
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
||||||||||||||
|
|
2026
|
2025
|
2026
|
2025
|
||||||||||||
|
|
||||||||||||||||
|
Net loss (U.S. GAAP)
|
$
|
(173
|
)
|
$
|
(85
|
)
|
$
|
(277
|
)
|
$
|
(196
|
)
|
||||
|
Interest expense
|
56
|
45
|
109
|
87
|
||||||||||||
|
Interest income
|
—
|
(1
|
)
|
(2
|
)
|
(3
|
)
|
|||||||||
|
Income tax provision
|
106
|
4
|
106
|
9
|
||||||||||||
|
Depreciation, depletion and amortization expense
|
76
|
74
|
151
|
145
|
||||||||||||
|
EBITDA (non-U.S. GAAP)
|
65
|
37
|
87
|
42
|
||||||||||||
|
Gain on sale of Fuzhou (a)
|
(20
|
)
|
—
|
(20
|
)
|
—
|
||||||||||
|
Share-based compensation (b)
|
5
|
4
|
11
|
9
|
||||||||||||
|
Accretion expense and other adjustments to asset retirement obligations and environmental liabilities (c)
|
6
|
7
|
10
|
14
|
||||||||||||
|
Accounts receivable securitization program (d)
|
4
|
3
|
7
|
7
|
||||||||||||
|
Foreign currency remeasurement (e)
|
7
|
(2
|
)
|
14
|
(1
|
)
|
||||||||||
|
Restructuring and other charges (f)
|
4
|
42
|
18
|
128
|
||||||||||||
|
Other items (g)
|
2
|
2
|
8
|
6
|
||||||||||||
|
Adjusted EBITDA (non-U.S. GAAP)
|
$
|
73
|
$
|
93
|
$
|
135
|
$
|
205
|
||||||||
|
|
Three Months Ended June 30,
|
|||||||
|
|
2026
|
2025
|
||||||
|
Net sales
|
$
|
868
|
|
$
|
731
|
|
||
|
Net loss (U.S. GAAP)
|
$ |
(173
|
) |
$ |
(85
|
) |
||
|
Net loss (U.S. GAAP) as a % of Net sales
|
(19.9
|
)% |
(11.6
|
)%
|
||||
|
Adjusted EBITDA (non-U.S. GAAP) (see above) as a % of Net sales
|
8.4
|
% |
12.7
|
% |
||||
|
|
|
|
||||||
|
|
June 30, 2026
|
December 31, 2025
|
||||||
|
Long-term debt, net
|
$ |
3,123
|
|
$ |
3,132
|
|||
|
Short-term debt
|
68
|
51 | ||||||
|
Long-term debt due within one year
|
39
|
39
|
||||||
|
(Less) Cash and cash equivalents
|
(194
|
) |
(199
|
) |
||||
|
Net debt (1)
|
$ |
3,036
|
$ |
3,023
|
|
|||
|
Trailing-twelve month Adjusted EBITDA (non-U.S. GAAP)
|
$ |
266
|
$ |
336
|
||||
|
Net debt to trailing-twelve month Adjusted EBITDA (non-U.S. GAAP) (see above)
|
11.4
|
x |
9.0 |
x |
||||
|
|
Six Months Ended
June 30, 2026
|
Three Months Ended
March 31, 2026 |
Three Months Ended
June 30, 2026
|
|||||||||
|
Cash used in operating activities
|
$
|
37
|
$
|
(68
|
)
|
$
|
105
|
|||||
|
Capital expenditures
|
(112
|
)
|
(67
|
)
|
(45
|
)
|
||||||
|
Free cash flow (non-U.S. GAAP)
|
$
|
(75
|
)
|
$
|
(135
|
)
|
$
|
60
|
||||
|
|
Three Months Ended
|
Trailing Twelve Month
|
||||||||||||||||||
|
|
September 30, 2025
|
December 31, 2025
|
March 31, 2026
|
June 30, 2026
|
Adjusted EBITDA
|
|||||||||||||||
|
|
||||||||||||||||||||
|
Net loss (U.S. GAAP)
|
$
|
(100
|
)
|
$
|
(177
|
)
|
$
|
(104
|
)
|
$
|
(173
|
)
|
$
|
(554
|
)
|
|||||
|
Interest expense
|
48
|
54
|
53
|
56
|
|
211
|
||||||||||||||
|
Interest income
|
(1
|
)
|
(2
|
)
|
(2
|
)
|
—
|
|
(5
|
)
|
||||||||||
|
Income tax provision (benefit)
|
8
|
(2
|
)
|
—
|
106
|
|
112
|
|||||||||||||
|
Depreciation, depletion and amortization expense
|
75
|
82
|
75
|
76
|
|
308
|
||||||||||||||
|
EBITDA (non-U.S. GAAP)
|
30
|
(45
|
)
|
22
|
65
|
|
72
|
|||||||||||||
|
Gain on sale of Fuzhou (a)
|
—
|
—
|
—
|
(20
|
)
|
|
(20
|
)
|
||||||||||||
|
Share-based compensation (b)
|
5
|
6
|
6
|
5
|
|
22
|
||||||||||||||
|
Foreign currency remeasurement (c)
|
—
|
7
|
7
|
7
|
|
21
|
||||||||||||||
|
Accretion expense and other adjustments to asset retirement obligations and environmental liabilities (d)
|
6
|
(11
|
)
|
4
|
6
|
|
5
|
|||||||||||||
|
Accounts receivable securitization program (e)
|
3
|
3
|
3
|
4
|
|
13
|
||||||||||||||
|
Restructuring and other charges (f)
|
25
|
79
|
14
|
4
|
|
122
|
||||||||||||||
|
Other items (g)
|
5
|
18
|
6
|
2
|
|
31
|
||||||||||||||
|
Adjusted EBITDA (non-U.S. GAAP)
|
$
|
74
|
$
|
57
|
$
|
62
|
$
|
73
|
$
|
266
|
||||||||||